Targeted and persistent effects of NO mediated by S-nitrosation of tissue thiols in arteries with endothelial dysfunction

Nitric Oxide - Biology and Chemistry

Volumn 17, Issue 1, 2007, Pages 1-9

  Sarr, Mamadou ^a,c,e   Chataigneau, Marta ^a,e   Etienne Selloum, Nelly ^a,e   Diallo, Aminata S ^c,e   Schott, Christa ^a,e   Geffard, Michel ^d,e   Stoclet, Jean Claude ^a,e   Schini Kerth, Valérie B ^a,e   Muller, Bernard ^b,c,e  

^a CNRS   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c CENTRE DE RECHERCHE CARDIO THORACIQUE DE BORDEAUX   (France)

^d UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^e PSL RESEARCH UNIVERSITY   (France)

Author keywords

Angiotensin II; Endothelial dysfunction; N acetylcysteine; Nitric oxide stores; Reactive oxygen species; S nitrosation

Indexed keywords

ACETYLCHOLINE; ACETYLCYSTEINE; ANGIOTENSIN II; MERCUROUS CHLORIDE; NITRIC OXIDE; SODIUM CHLORIDE; THIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY; ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; MALE; NITROSATION; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS; VASCULAR RING;

ANGIOTENSIN II; ANIMALS; ANIONS; CYSTEINE; ENDOTHELIUM, VASCULAR; MALE; MODELS, BIOLOGICAL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROGEN; OXIDATIVE STRESS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SULFHYDRYL COMPOUNDS;

RATTUS;

EID: 34447500300     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2007.04.003     Document Type: Article

References (41)

1. Albrecht E.W., Stegemen C.A., Heeringa P., Henning R.H., and Van Goor H. Protective role of endothelial nitric oxide synthase. J. Pathol. 199 (2003) 8-17
2. Gewaltig M.T., and Kojda G. Vasoprotection by nitric oxide: mechanisms and therapeutic potentials. Cardiovasc. Res. 55 (2002) 250-260
3. Li H., and Forstermann U. Nitric oxide in the pathogenesis of vascular disease. J. Pathol. 190 (2000) 244-254
4. Schini-Kerth V.B. Vascular biosynthesis of nitric oxide: effect on hemostasis and fibrinolysis. Transfus. Clin. Biol. 6 (1999) 355-363
5. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87 (2000) 840-844
6. Griendling K.K., and Fitzgerald G.A. Oxidative stress and cardiovascular injury: Part II: animal and human studies. Circulation 108 (2003) 2034-2040
7. Taniyama Y., and Griendling K.K. Reactive oxygen species in the vasculature : molecular and cellular mechanisms. Hypertension 42 (2003) 1075-1081
8. Landmesser U., Hornig B., and Drexler H. Endothelial function: a critical determinant in atherosclerosis?. Circulation 109 (2004) II27-II33
9. Alencar J.L., Lobysheva I., Geffard M., Sarr M., Schott C., Schini-Kerth V., Nepveu F., Stoclet J.C., and Muller B. Role of S-nitrosation of cysteine residues in long-lasting inhibitory effect of NO on arterial tone. Mol. Pharmacol. 63 (2003) 1148-1158
10. Alencar J.L., Lobysheva I., Chalupsky K., Geffard M., Nepveu F., Stoclet J.C., and Muller B. S-nitrosating nitric oxide donors induce long-lasting inhibition of contraction in isolated arteries. J. Pharmacol. Exp. Ther. 307 (2003) 152-159
11. Alencar J.L., Chalupsky K., Sarr M., Schini-Kerth V.B., Vanin A.F., Stoclet J.C., and Muller B. Inhibition of arterial contraction by dinitrosyl-iron complexes: critical role of the thiol ligand in determining rate of nitric oxide (NO) release and formation of releasable NO stores by S-nitrosation. Biochem. Pharmacol. 66 (2003) 2365-2374
12. Megson I.L., R Greig I., Gray G.A., Webb D.J., and Butler A.R. Prolonged effect of a novel S-nitrosated glyco-amino acid in endothelium-denuded rat femoral arteries: potential as a slow release nitric oxide donor drug. Br. J. Pharmacol. 122 (1997) 1617-1624
13. Megson I.L., Morton S., Greig I.R., Mazzei F.A., Field R.A., Butler A.R., Caron G., Gasco A., Fruttero R., and Webb D.J. N-substituted analogues of S-nitroso-N-acetyl-d,l-penicillamine: chemical stability and prolonged nitric oxide mediated vasodilatation in isolated rat femoral arteries. Br. J. Pharmacol. 126 (1999) 639-648
14. Sogo N., Campanella C., Webb D.J., and Megson I.L. S-nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery. Br. J. Pharmacol. 131 (2000) 1236-1244
15. Terluk M.R., Da Silva-Santos J.E., and Assreuy J. Involvement of soluble guanylate cyclase and calcium-activated potassium channels in the long-lasting hyporesponsiveness to phenylephrine induced by nitric oxide in rat aorta. Naunyn Schmiedebergs Arch. Pharmacol. 361 (2000) 477-483
16. Sarr M., Lobysheva I., Diallo A.S., Stoclet J.C., Schini-Kerth V.B., and Muller B. Formation of releasable NO stores by S-nitrosoglutathione in arteries exhibiting tolerance to glyceryl-trinitrate. Eur. J. Pharmacol. 513 (2005) 119-123
17. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., and Harrison D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 97 (1996) 1916-1923
18. Sarr M., Chataigneau M., Martins S., Schott C., El Bedoui J., Oak M.O., Muller B., Chataigneau T., and Schini-Kerth V.B. Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase. Cardiovasc. Res. 71 (2006) 794-802
19. Munzel T., Daiber A., and Mulsch A. Explaining the phenomenon of nitrate tolerance. Circ. Res. 97 (2005) 618-628
20. Shinozaki K., Ayajiki K., Nishio Y., Sugaya T., Kashiwagi A., and Okamura T. Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance. Hypertension 43 (2004) 255-262
21. Scharfstein J.S., Keaney J.F., Slivka A., Welch G.N., Vita J.A., Stamler J.S., and Loscalzo J. In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J. Clin. Invest. 94 (1994) 1432-1439
22. Saville B. A scheme for the colorimetric determination of microgram amounts of thiols. Analyst 83 (1958) 670-672
23. Fresquet F., Pourageaud F., Leblais V., Brandes R.P., Savineau J.P., Marthan R., and Muller B. Role of reactive oxygen species and gp91phox in endothelial dysfunction of pulmonary arteries induced by chronic hypoxia. Br. J. Pharmacol. 148 (2006) 714-723
24. Lorch S.A., Foust III R., Gow A., Arkovitz M., Salzman A.L., Szabo C., Veyret B., Geffard M., and Ischiropoulos H. Immunohistochemical localization of protein 3-nitrotyrosine and S-nitrosocysteine in a murine model of inhaled nitric oxide therapy. Pediatr. Res. 47 (2000) 798-805
25. Mnaimneh S., Geffard M., Veyret B., and Vincendeau P. Albumin nitrosylated by activated macrophages possesses antiparasitic effects neutralized by anti-NO-acetylated-cysteine antibodies. J. Immunol. 158 (1997) 308-314
26. Mollnau H., Wendt M., Szocs K., Lassegue B., Schulz E., Oelze M., Li H., Bodenschatz M., August M., Kleschyov A.L., Tsilimingas N., Walter U., Forstermann U., Meinertz T., Griendling K., and Munzel T. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ. Res. 90 (2002) E58-E65
27. Oelze M., Daiber A., Brandes R.P., Hortmann M., Wenzel P., Hink U., Schulz E., Mollnau H., von Sandersleben A., Kleschyov A.L., Mulsch A., Li H., Forstermann U., and Munzel T. Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats. Hypertension 48 (2006) 677-684
28. Pagano P.J., Clark J.K., Cifuentes-Pagano M.E., Clark S.M., Callis G.M., and Quinn M.T. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc. Natl. Acad. Sci. USA 94 (1997) 14483-14488
29. Kane M.O., Etienne N., Sarr M., Chataigneau M., Walter A., Schott C., and Schini-Kerth V.B. Endothelial dysfunction is related to cycclooxygenases metabolites, the endothelium-derived contracting factors (EDCF), in angiotensin II-induced hypertension in rats. Fundam. Clin. Pharmacol. 20 (2006) 145-234 abstract
30. Terluk M., Cunha Da Silva E., Antunes T., and Assreuy J. The presence of the endothelial layer reduces nitric oxide-induced hyporesponsiveness to phenylephrine in rat aorta. Endothelium 11 (2004) 181-187
31. Moncada S., Rees D.D., Schulz R., and Palmer R.M. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc. Natl. Acad. Sci. USA 88 (1991) 2166-2170
32. Muller B., Kleschyov A.L., Malblanc S., and Stoclet J.C. Nitric oxide-related cyclic GMP-independent relaxing effect of N-acetylcysteine in lipopolysaccharide-treated rat aorta. Br. J. Pharmacol. 123 (1998) 1221-1229
33. Muller B., Kleschyov A.L., and Stoclet J.C. Evidence for N-acetylcysteine-sensitive nitric oxide storage as dinitrosyl-iron complexes in lipopolysaccharide-treated rat aorta. Br. J. Pharmacol. 119 (1996) 1281-1285
34. Hernanz R., Alonso M.J., Zibrandtsen H., Alvarez Y., Salaices M., and Simonsen U. Measurements of nitric oxide concentration and hyporeactivity in rat superior mesenteric artery exposed to endotoxin. Cardiovasc. Res. 62 (2004) 202-211
35. Nozik-Grayck E., Whalen E.J., Stamler J.S., McMahon T.J., Chitano P., and Piantadosi C.A. S-nitrosoglutathione inhibits alpha1-adrenergic receptor-mediated vasoconstriction and ligand binding in pulmonary artery. Am. J. Physiol. Lung Cell. Mol. Physiol. 290 (2006) L136-L143
36. Leclerc P.C., Lanctot P.M., Auger-Messier M., Escher E., Leduc R., and Guillemette G. S-nitrosylation of cysteine 289 of the AT1 receptor decreases its binding affinity for angiotensin II. Br. J. Pharmacol. 148 (2006) 306-313
37. Gow A.J., Chen Q., Hess D.T., Day B.J., Ischiropoulos H., and Stamler J.S. Basal and stimulated protein S-nitrosylation in multiple cell types and tissues. J. Biol. Chem. 277 (2002) 9637-9640
38. Miller M.R., Hanspal I.S., Hadoke P.W., Newby D.E., Rossi A.G., Webb D.J., and Megson I.L. A novel S-nitrosothiol causes prolonged and selective inhibition of platelet adhesion at sites of vascular injury. Cardiovasc. Res. 57 (2003) 853-860
39. Walford G., and Loscalzo J. Nitric oxide in vascular biology. J. Thromb. Haemost. 1 (2003) 2112-2118
40. Muller B., Kleschyov A.L., Alencar J.L., Vanin A., and Stoclet J.C. Nitric oxide transport and storage in the cardiovascular system. Ann. NY Acad. Sci. 962 (2002) 131-139
41. Megson I.L., Holmes S.A., Magid K.S., Pritchard R.J., and Flitney F.W. Selective modifiers of glutathione biosynthesis and 'repriming' of vascular smooth muscle photorelaxation. Br. J. Pharmacol. 130 (2000) 1575-1580